|
|
|
|
|
|
|
|
|
|
Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer -- Mutch et al. 25 (19): 2811 -- Journal of Clinical Oncology
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
ovarian cancer
Ovarian Cancer Awareness (teal)
ovarian cancer
Ovarian Cancer
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.